Subject(s)
Actinomycosis/drug therapy , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Mandible/pathology , Osteomyelitis/drug therapy , Osteomyelitis/pathology , Actinomycosis/pathology , Adjuvants, Pharmaceutic/therapeutic use , Anti-Bacterial Agents/therapeutic use , Biopsy , Child , Chronic Disease , Debridement , Female , Follow-Up Studies , Humans , Osteomyelitis/surgery , Treatment OutcomeABSTRACT
OBJECTIVE: The American Academy of Pediatrics recommends intramuscular (IM) vitamin K prophylaxis for all newborns to prevent vitamin K deficiency bleeding. Given the serious implications of late-onset vitamin K deficiency bleeding, our objective was to examine factors influencing parents' decisions to refuse IM vitamin K prophylaxis. METHODS: Parents intending to refuse IM vitamin K prophylaxis at delivery were recruited from 5 community hospitals, 1 academic medical center, and 2 birthing centers in a single Southeastern state. Participants completed a written survey including demographics, birth and parenting decisions (eg, breastfeeding), and open-ended questions about their vitamin K information sources, concerns, and knowledge of risks. RESULTS: The incidence of refusal was highest at the birthing centers. Fifty-four parents intending to refuse IM vitamin K completed the survey. Most were white (78%), over age 30 (57%), and college graduates (65%). All reported intention to exclusively breastfeed. Most refused hepatitis B vaccine (90%) and erythromycin eye ointment (77%). The most common source of information was the Internet (70%). Concerns included synthetic or toxic ingredients (37%), excessive dose (28%), and side effects (24%). Eighty-three percent of parents reported awareness of risks associated with vitamin K refusal. However, only 6 parents (11%) decided to accept IM prophylaxis. CONCLUSIONS: This study provides an understanding of the concerns, mindset, and information sources used by parents refusing IM vitamin K. Educating parents about the importance of IM prophylaxis should begin in the prenatal period and must address concerns parents identify on the Internet.
Subject(s)
Chemoprevention , Parents , Patient Medication Knowledge/methods , Treatment Refusal , Vitamin K Deficiency Bleeding/prevention & control , Vitamin K/administration & dosage , Adult , Antifibrinolytic Agents/administration & dosage , Chemoprevention/methods , Chemoprevention/psychology , Female , Health Knowledge, Attitudes, Practice , Humans , Incidence , Infant, Newborn , Injections, Intramuscular , Male , Parents/education , Parents/psychology , Surveys and Questionnaires , Treatment Refusal/psychology , Treatment Refusal/statistics & numerical data , United StatesABSTRACT
Despite the publication of a number of case reports since the 1950s, physician awareness of the unique relationship between cat scratch disease (CSD) and acute encephalopathy remains limited. This report alerts emergency medicine physicians to include CSD encephalopathy (CSDE) in the differential diagnosis when a previously healthy child presents with status epilepticus. Prompt recognition of this relationship impacts the selection of initial diagnostic studies and antibiotic choices and permits reliable insight into prognosis. The 2 cases are from different eras and demonstrate the significant diagnostic advances in the past 3 decades for Bartonella henselae infection. Both children were treated with antibiotics, and both had resolution of all neurological symptoms. However, the role of antibiotics in the treatment and outcome of CSDE remains speculative. Lastly, the report suggests potential areas of investigation to address immune-mediated mechanisms in the pathogenesis of CSDE.
Subject(s)
Angiomatosis, Bacillary/diagnosis , Bartonella henselae/isolation & purification , Cat-Scratch Disease/diagnosis , Status Epilepticus/etiology , Angiomatosis, Bacillary/drug therapy , Anti-Bacterial Agents/administration & dosage , Cat-Scratch Disease/drug therapy , Child, Preschool , Diagnosis, Differential , Female , Humans , Male , Status Epilepticus/drug therapy , Treatment OutcomeSubject(s)
Brown Recluse Spider , Spider Bites/diagnosis , Anti-Bacterial Agents/therapeutic use , Blood Transfusion/methods , Child , Diagnosis, Differential , Exanthema/etiology , Exanthema/therapy , Female , Humans , Methylprednisolone/therapeutic use , North Carolina , Pulmonary Edema/etiology , Pulmonary Edema/therapy , Shock, Septic/drug therapy , Shock, Septic/etiology , Spider Bites/complications , Spider Bites/therapy , Tachycardia/etiology , Tachycardia/therapy , Tachypnea/etiology , Tachypnea/therapyABSTRACT
Cryoglobulinemia is rarely reported in children, and kidney failure secondary to cryoglobulinemia is even more uncommon. We report the case of a 7-year-old boy with cryoglobulins and a systemic illness, including persistent fever, arthralgias, rash, hypocomplementemia, and acute kidney injury associated with nephritic urine sediment. An extensive workup showed no infectious, neoplastic, or rheumatological cause of his kidney injury. The kidney biopsy specimen showed membranoproliferative glomerulonephritis type 1 with electron microscopic evidence of rhomboid crystalloid inclusions. These inclusions have rarely been reported in adult patients with cryoglobulinemia. The patient underwent spontaneous remission, including full recovery of kidney function, and required no immune suppression. The patient's course is consistent with cryoglobulinemia-associated kidney injury, which supports the inclusion of essential cryoglobulinemia in the differential diagnosis of pediatric patients with hypocomplementemic glomerulonephritis.
Subject(s)
Acute Kidney Injury/etiology , Cryoglobulinemia/complications , Kidney Glomerulus/ultrastructure , Acute Kidney Injury/blood , Acute Kidney Injury/pathology , Biopsy , Child , Complement System Proteins/metabolism , Cryoglobulinemia/blood , Cryoglobulinemia/pathology , Diagnosis, Differential , Glomerulonephritis, Membranoproliferative/blood , Glomerulonephritis, Membranoproliferative/complications , Glomerulonephritis, Membranoproliferative/pathology , Humans , Male , Microscopy, ElectronABSTRACT
We describe 2 children with prolonged fever of unknown origin and prominent skeletal pain who had multifocal bone disease caused by Bartonella infection. Initial radiologic studies, including plain films, radionuclide scintigraphy and computed tomography, yielded negative results. In both cases, magnetic resonance imaging revealed multiple enhancing bone marrow lesions consistent with clinical symptoms. Microbiologic diagnoses were established serologically.
Subject(s)
Bartonella henselae/isolation & purification , Bone Marrow/pathology , Cat-Scratch Disease/diagnosis , Osteomyelitis/diagnosis , Osteomyelitis/microbiology , Animals , Anti-Bacterial Agents/therapeutic use , Bone Marrow/microbiology , Cat-Scratch Disease/complications , Child , Child, Preschool , Female , Follow-Up Studies , Humans , Magnetic Resonance Imaging/methods , Male , Osteomyelitis/drug therapy , Risk Assessment , Severity of Illness Index , Tomography, X-Ray Computed/methods , Treatment OutcomeABSTRACT
Tick paralysis is an acute, progressive, and potentially fatal muscle paralysis secondary to a toxin secreted by a pregnant tick during a bite. Although tick bites can occur anywhere on the body, ticks are frequently overlooked on the scalp because of overlying hair. Children with acute neurologic symptoms frequently undergo MR scanning that may incidentally reveal the offending tick. Timely identification and removal of the tick leads to rapid recovery from tick paralysis. We report the MRI findings at 1.5 T of tick paralysis with an attached tick.
Subject(s)
Magnetic Resonance Imaging , Skull/pathology , Tick Paralysis/diagnosis , Child, Preschool , Female , Humans , Scalp/pathologyABSTRACT
An 8-year-old girl with a progressive systemic hemopagocytic syndrome was found to have non-Hodgkin lymphoma (NHL) after multiple nondiagnostic biopsies. Routine histochemistry and flow cytometry demonstrated this to be a peripheral T-cell process and cytogenetics identified a t(2;5)(p23;q35). An extensive evaluation for an infectious agent failed to identify a pathogen. Treatment according to a standard lymphoma protocol produced a rapid response and the girl remains in remission without evidence of hemophagocytic syndrome 18 months from diagnosis. In children with systenic hemophagocytosis, a diagnosis of NHL should be aggressively pursued.